1. DNA damages promoted by the essential oil from leaves of Casearia sylvestris Sw. (Salicaceae)
   G. Pereira Flaviane et al, 2016, J. Med. Plants Res. CrossRef
2. PUMA-dependent apoptosis in NSCLC cancer cells by a dimeric β-carboline
   Jaruwan Chatwichien et al, 2016, Bioorganic & Medicinal Chemistry Letters CrossRef
3. 7- O -geranylquercetin-induced autophagy contributes to apoptosis via ROS generation in human non-small cell lung cancer cells
   En-Xia Wang et al, 2017, Life Sciences CrossRef
4. A novel synthetic curcumin derivative MHMM-41 induces ROS-mediated apoptosis and migration blocking of human lung cancer cells A549
   Guang-Zhou Zhou et al, 2018, Biomedicine & Pharmacotherapy CrossRef
5. Quercetin and its metabolite isorhamnetin promote glucose uptake through different signalling pathways in myotubes
   Hao Jiang et al, 2019, Sci Rep CrossRef
6. Delivery of natural phenolic compounds for the potential treatment of lung cancer
   Ashley G. Muller et al, 2019, DARU J Pharm Sci CrossRef
7. ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine
   Jinjiao Hu et al, 2019, J Exp Clin Cancer Res CrossRef
8. Isorhamnetin inhibited migration and invasion via suppression of Akt/ERK-mediated epithelial-to-mesenchymal transition (EMT) in A549 human non-small-cell lung cancer cells
   Wei Luo et al, 2019, Biosci. Rep. CrossRef
9. CNOT2 Is Critically Involved in Atorvastatin Induced Apoptotic and Autophagic Cell Death in Non-Small Cell Lung Cancers
   Jihyun Lee et al, 2019, Cancers CrossRef
10. Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells
    null Park et al, 2019, Cancers CrossRef
11. Anti-cancer effects of Polyphyllin I: An update in 5 years
    Ye Tian et al, 2019, Chemico-Biological Interactions CrossRef
12. Recent Advances in Characterizing Natural Products that Regulate Autophagy
    Qian Zhao et al, 2020, ACAMC CrossRef
13. Isorhamnetin: A review of pharmacological effects.
    Gang Gong et al, 2020, Biomed Pharmacother CrossRef
14. Quinalizarin exerts an anti-tumour effect on lung cancer A549 cells by modulating the Akt, MAPK, STAT3 and p53 signalling pathways.
    Ling-Qi Meng et al, 0 CrossRef
15. Cytotoxic action of methylquercetins in human lung adenocarcinoma cells
    Katrin Sak et al, 2017, Oncol Lett CrossRef
16. Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies
    Monica Benvenuto et al, 2020, IJMS CrossRef
17. Knockdown of TRAP1 promotes cisplatin-induced apoptosis by promoting the ROS-dependent mitochondrial dysfunction in lung cancer cells
    Xiaowei Zhang et al, 2020, Mol Cell Biochem CrossRef
18. Epigenetic modulation of autophagy genes linked to diabetic nephropathy by administration of isorhamnetin in Type 2 diabetes mellitus rats
    Marwa Matboli et al, 2021, Epigenomics CrossRef
19. Isorhamnetin Inhibits Human Gallbladder Cancer Cell Proliferation and Metastasis via PI3K/AKT Signaling Pathway Inactivation
    Tianyu Zhai et al, 2021, Front. Pharmacol. CrossRef
20. Exploring the mechanism of aidi injection for lung cancer by network pharmacology approach and molecular docking validation
    Zhenjie Zhuang et al, 2021 CrossRef
21. Isorhamnetin Promotes Estrogen Biosynthesis and Proliferation in Porcine Granulosa Cells via the PI3K/Akt Signaling Pathway.
    Xiaoya Li et al, 2021, J Agric Food Chem CrossRef
22. Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
    Zdeněk Kejík et al, 2021, Pharmaceutics CrossRef
23. Single-synapse analyses of Alzheimer’s disease implicate pathologic tau, DJ1, CD47, and ApoE
    Thanaphong Phongpreecha et al, 2021, Sci. Adv. CrossRef
24. Isorhamnetin Suppresses Human Gastric Cancer Cell Proliferation through Mitochondria-Dependent Apoptosis
    Yehua Li et al, 2022, Molecules CrossRef
25. Crosstalk between xanthine oxidase (XO) inhibiting and cancer chemotherapeutic properties of comestible flavonoids- a comprehensive update
    Md Sohanur Rahaman et al, 2022, The Journal of Nutritional Biochemistry CrossRef
26. Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
    Abdelrahim Alqudah et al, 2023, Molecules CrossRef
27. Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds
    Neeraj Choudhary et al, 2023, Cancers CrossRef
28. Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer
    Kangwook Lee et al, 2024, BMC Complement Med Ther CrossRef
29. Isorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?
    Jiaming Lei et al, 2024, Front. Pharmacol. CrossRef
30. Selected Flavonols Targeting Cell Death Pathways in Cancer Therapy: The Latest Achievements in Research on Apoptosis, Autophagy, Necroptosis, Pyroptosis, Ferroptosis, and Cuproptosis
    Dominika Wendlocha et al, 2024, Nutrients CrossRef
31. The experimental significance of isorhamnetin as an effective therapeutic option for cancer: A comprehensive analysis
    Partha Biswas et al, 2024, Biomedicine & Pharmacotherapy CrossRef
32. Quercetin and its nanoformulations as promising agents for lung cancer treatment: A focus on molecular mechanisms
    Reza Arefnezhad et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
33. Isorhamnetin Improves Oocyte Maturation by Activating the Pi3k/Akt Signaling Pathway
    Xiaoya Li et al, 2024, Molecular Nutrition Food Res CrossRef
34. Study on Molecular Mechanism of Compound Cantharidin against NSCLC Based on Network Pharmacology
    宗阁 沙, 2024, TCM CrossRef